Results 141 to 150 of about 56,684 (289)
Redefining “Comorbidity” in Dermatology: Beyond Terminology, Lessons From Other Specialties
JEADV Clinical Practice, EarlyView.
Patricia Garbayo‐Salmons +1 more
wiley +1 more source
Investigating the Effect of Tumour Necrosis Factor Antagonist on Olfaction
ABSTRACT Objectives Tumour Necrosis factor antagonists is a potent anti‐inflammatory medication and has shown to improve olfactory function in murine models. The primary aim was to determine the effect of TNF antagonists on olfactory performance in humans.
Andreas Espehana +7 more
wiley +1 more source
Enteropathic spondyloarthritis [PDF]
The inflammatory bowel diseases are chronic idiopathic inflammatory diseases of the gastrointestinal tract that may be complicated by a variety of extraintestinal manifestations such as primary sclerosing cholangitis, erythema nodosum, pyoderma ...
Mrsić, Fanika
core
Positive and Negative Cardiovascular Effects of JAK Inhibitors in Inflammation
Chronic inflammation, characteristic of many autoimmune diseases, such as rheumatoid arthritis (RA), or myeloproliferative neoplasms (MPNs), is an independent driver of accelerated cardiovascular (CV) risk, primarily through proinflammatory cytokines that induce atherosclerosis and endothelial dysfunction.
Aliki Zavoriti, Pierre Miossec
wiley +1 more source
Objective To investigate the prevalence of electrocardiographic changes in patients with spondyloarthritis and to correlate these changes with use of anti-tumor necrosis factor-alpha (TNF-α) drugs and HLA-B27 positivity.
Betânia Longo +4 more
doaj +1 more source
ABSTRACT Background Remission, a term used to describe a goal of treatment for some chronic diseases, has recently been proposed for chronic rhinosinusitis (CRS). However, it is unclear what remission means for CRS and why it should serve as a goal in the present‐day treatment of CRS.
Nikhil Parail +7 more
wiley +1 more source
Current treatment for spondyloarthritis: focus on netakimab. A review
Spondyloarthritis (SpA) is a group of rheumatic diseases that includes ankylosing spondylitis (AS), psoriatic arthritis (PsA) and a number of other diseases. SpA lead to a significant social problem, since it is a common pathology that debuts mainly at a
Dmitry E. Karateev, Elena L. Luchikhina
doaj +1 more source
Should TNF inhibitors be avoided in psoriasis patients with latent tuberculosis?
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Fabià Torres‐Betato, Lluís Puig
wiley +1 more source
ABSTRACT Ankylosing spondylitis (AS) is a chronic immune‐mediated inflammatory arthropathy primarily affecting the axial skeleton but may involve peripheral joints, particularly the hips. Avascular necrosis (AVN) of the femoral head represents a severe, underrecognized complication whose pathogenesis in AS is multifactorial—encompassing disease ...
Syeda Simrah Shah +5 more
wiley +1 more source
Objective: This study aimed to establish a correlation between fecal calprotectin levels (FC) and intestinal inflammation in patients with spondyloarthritis without inflammatory bowel disease.
Juliette De Avila +14 more
doaj +1 more source

